ABACAVIR DOSING IN NEONATES FROM BIRTH: A PHARMACOKINETIC ANALYSIS
Antiretroviral treatment (ART) from birth in neonates (3 months of age (8 mg/kg, BID), while the WHO recommends weight band dosing for children ?4 weeks weighing ?3 to
Abstracts
Antiretroviral treatment (ART) from birth in neonates (3 months of age (8 mg/kg, BID), while the WHO recommends weight band dosing for children ?4 weeks weighing ?3 to
SARS-CoV2 infection severity during pregnancy and posible consequences for exposed newborns information is still unknown. The objective of this study is to analyse clinical and epidemiological characteristics of a SARS-CoV2 infected women during pregnancy and their newborns cohort. Multicentric observational study from the Spanish GENEO-COVID cohort (participating in RECLIP). Infected pregnant women and their newborns…
Potential effects of infection with SARS-CoV-2 in pregnant women are still conflicted. Initial symptoms for COVID-19 are often unspecific, it is thus clinically relevant to know if a positive naso-pharyngeal real time reverse transcription PCR (RT-PCR) for SARS-CoV-2 at evaluation is predictive of perinatal outcomes. Our objective was to determine the impact of SARS-CoV-2 infection…
Maternal antibodies are important for infant immunity, and understanding the maternal and umbilical cord antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection will be important for neonatal management and maternal vaccination strategies. The dynamics of maternal/ umbilical cord antibody responses to the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein were analyzed…
The UK has met 90-90-90 targets since 2017 and a major success has been the low vertical HIV transmission rate (VTR), declining from 2.1% in 2000-01 to 0.28% in 2015-16 among diagnosed women living with HIV (WLHIV). The British HIV Association (BHIVA) recommends follow-up of all infants of WLHIV at 18-24mths (’18-24Ab’), regardless of negative…
PROMISE 1077BF/1077FF was a multi-site, randomized, open-label, perinatal trial comparing the relative safety/efficacy of proven ARV regimens during pregnancy and breastfeeding (BF) among HIV+ women not meeting treatment criteria at trial entry. Previous results found
Young women in sub-Saharan Africa are at particularly high risk of HIV acquisition. Recent shifts toward ‘test and treat’ strategies have potential to reduce transmission in this age group, but have not been widely studied outside of clinical trials. Using data from nationwide surveillance among pregnant women in Botswana, where a ‘test and treat’ strategy…
Understanding adolescent motherhood and HIV infection in resource-constrained settings is critical. In this study, we report HIV treatment-related outcomes and clinic factors associated with poor treatment outcomes among adolescent mothers living with HIV in South Africa. All adolescent girls living with HIV from 52 clinics and 9 maternity obstetric units in a health district in…
Few data exist on early life metabolic perturbations in newborns with in utero HIV and antiretroviral therapy (ART) exposure who are HIV uninfected (HEU). We measured pre-prandial insulin and glucose at birth (within 72 hours of life) and 1 month (mo) to calculate Homeostasis Model Assessment for Insulin Resistance (HOMA) in newborns HEU and newborns…
Children who are HIV-exposed, uninfected (HEU) have worse neurodevelopmental (ND) outcomes compared to children who are HIV-unexposed (HU), but assessing ND in resource-poor settings is challenging. We measured cognitive, language and motor development in HEU and HU paired with pro- and anti-inflammatory plasma biomarkers in each child to identify potential biomarkers of poor ND outcomes.…